Corbus Pharma (CRBP) Reports Q4 Loss of $0.28/Share

Corbus Pharma (NASDAQ: CRBP) reported Q4 EPS of ($0.28), versus ($0.13) reported last year. Revenue for the quarter came in at $648.4 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Mizuho
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c